Multiplex Assays Market size, Growth, Forecast 2023 JUNE 2018

Multiplex Assays Market by Product (Consumables, Instruments), Type (Nucleic
Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence), Application
(R&D, Diagnosis), End User (Pharma & Biotech, Reference Laboratory, Hospital) -
Global Forecast to 2023
The Market Research on Multiplex Assays, By Considering useful aspects like; Material, Product,
Application, End User (Hospital, ASCs) - Global Future Forecast till 2023, published by
MarketsandMarkets™, the report studies the global Multiplex Assays market over the forecast
period of 2017 to 2023. The market is projected to reach USD 3.35 Billion by 2023 at a CAGR of
7.5%.
The study estimates the Multiplex Assays market size for 2018 and projects its demand till
2023. In the primary research process, various sources from both demand side and supply side
were interviewed to obtain qualitative and quantitative information for the report. Primary
sources from the demand side include research scientists, Multiplex Assays specialists,
laboratory technicians, and R&D professionals of pharmaceutical and biotechnology companies
and academic research institutes.
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global multiplex
assays market and estimate the size of various other dependent submarkets. Major players in
the market were identified through secondary research and their market presence was studied
through primary and secondary research. Secondary research included the study of the annual
and financial reports of top market players, white papers, medical journals, certified
publications, articles from recognized authors, directories, and databases such as Statista,
World Health Organization (WHO), Organization for Economic Co-operation and Development
(OECD), Centers for Disease Control and Prevention (CDC), International Cytokine and
Interferon Society (ICIS), Diagnostic Marketing Association, American Clinical Laboratory
Association (ACLA), National Health Service (NHS), whereas primary research included extensive
interviews with key opinion leaders such as CEOs, directors, and marketing executives.
The Multiplex Assays market is fragmented with the presence of emerging players;
Luminex (US)
1